Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $24,062 | 1,217 | 70.5% |
| Consulting Fee | $9,170 | 2 | 26.9% |
| Education | $527.65 | 10 | 1.5% |
| Honoraria | $350.00 | 1 | 1.0% |
| Travel and Lodging | $18.00 | 1 | 0.1% |
| Gift | $7.36 | 8 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| UCB, Inc. | $8,241 | 19 | $0 (2024) |
| Galderma Laboratories, L.P. | $4,528 | 281 | $0 (2024) |
| ABBVIE INC. | $3,454 | 196 | $0 (2024) |
| Janssen Biotech, Inc. | $1,964 | 88 | $0 (2024) |
| Allergan, Inc. | $1,774 | 10 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $1,152 | 62 | $0 (2024) |
| Dermavant Sciences, Inc. | $1,145 | 57 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $1,053 | 62 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $1,026 | 34 | $0 (2024) |
| GENZYME CORPORATION | $871.10 | 33 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,437 | 208 | ABBVIE INC. ($643.19) |
| 2023 | $11,210 | 170 | UCB, Inc. ($7,801) |
| 2022 | $2,774 | 151 | ABBVIE INC. ($712.33) |
| 2021 | $2,503 | 133 | Galderma Laboratories, L.P. ($735.74) |
| 2020 | $2,515 | 134 | Galderma Laboratories, L.P. ($867.17) |
| 2019 | $3,503 | 145 | Galderma Laboratories, L.P. ($1,080) |
| 2018 | $2,040 | 149 | Galderma Laboratories, L.P. ($553.74) |
| 2017 | $5,154 | 149 | Allergan Inc. ($1,689) |
All Payment Transactions
1,239 individual payment records from CMS Open Payments — Page 1 of 50
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: Inflammation & Immunology | ||||||
| 12/17/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $22.57 | General |
| Category: DERMATOLOGY | ||||||
| 12/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $10.27 | General |
| Category: DERMATOLOGY | ||||||
| 12/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $7.91 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $26.88 | General |
| Category: Immunology | ||||||
| 12/03/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.30 | General |
| Category: FACIAL AESTHETICS | ||||||
| 12/03/2024 | Organon Llc | HADLIMA (Drug) | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: ADALIMUMAB-BWWD | ||||||
| 12/02/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $42.12 | General |
| Category: Immunology | ||||||
| 12/02/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $7.74 | General |
| 12/02/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $3.47 | General |
| Category: DERMATOLOGY | ||||||
| 11/25/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $40.35 | General |
| Category: Immunology | ||||||
| 11/25/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $2.11 | General |
| Category: Dermatology | ||||||
| 11/23/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: DERMATOLOGY | ||||||
| 11/21/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $188.36 | General |
| Category: Dermatology | ||||||
| 11/21/2024 | Verrica Pharmaceuticals Inc. | YCANTH (Drug) | Food and Beverage | In-kind items and services | $37.67 | General |
| Category: DERMATOLOGY | ||||||
| 11/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $5.13 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/19/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $22.42 | General |
| Category: ONCOLOGY | ||||||
| 11/19/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: Dermatology | ||||||
| 11/19/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $7.14 | General |
| Category: Dermatology | ||||||
| 11/18/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $24.70 | General |
| Category: DERMATOLOGY | ||||||
| 11/18/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $4.54 | General |
| Category: Dermatology | ||||||
| 11/14/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $9.68 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $3.47 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 2,512 | 6,381 | $1.1M | $450,983 |
| 2022 | 22 | 2,431 | 5,560 | $943,500 | $370,562 |
| 2021 | 23 | 2,535 | 6,643 | $1.2M | $461,805 |
| 2020 | 21 | 2,318 | 4,635 | $651,335 | $222,129 |
All Medicare Procedures & Services
87 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77280 | Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | Office | 2023 | 36 | 634 | $374,060 | $141,245 | 37.8% |
| G6001 | Ultrasonic guidance for placement of radiation therapy fields | Office | 2023 | 39 | 665 | $186,200 | $98,622 | 53.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 641 | 917 | $148,549 | $60,378 | 40.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 341 | 435 | $105,270 | $37,288 | 35.4% |
| 77401 | Superficial and/or low voltage radiation treatment delivery | Office | 2023 | 36 | 606 | $55,752 | $20,650 | 37.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 384 | 519 | $73,698 | $20,462 | 27.8% |
| 77427 | Radiation treatment management, 5 treatment sessions | Office | 2023 | 34 | 86 | $35,862 | $13,628 | 38.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 168 | 180 | $39,060 | $12,258 | 31.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 299 | 1,706 | $22,178 | $9,189 | 41.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 65 | 90 | $21,060 | $8,130 | 38.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 164 | 199 | $19,701 | $7,586 | 38.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 100 | 100 | $23,300 | $7,505 | 32.2% |
| 77334 | Design and construction of complex radiation treatment device | Office | 2023 | 27 | 34 | $9,248 | $3,423 | 37.0% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 23 | 24 | $8,184 | $3,318 | 40.5% |
| 77300 | Calculation of radiation therapy dose | Office | 2023 | 34 | 41 | $5,822 | $2,202 | 37.8% |
| 77261 | Simple radiation therapy planning | Office | 2023 | 28 | 29 | $4,524 | $1,630 | 36.0% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 21 | 21 | $3,465 | $995.42 | 28.7% |
| 69100 | Biopsy of ear | Office | 2023 | 18 | 18 | $3,852 | $960.17 | 24.9% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 20 | 25 | $2,975 | $888.37 | 29.9% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 13 | 14 | $1,624 | $592.89 | 36.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 21 | 38 | $114.00 | $31.49 | 27.6% |
| 77280 | Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | Office | 2022 | 26 | 398 | $234,820 | $90,618 | 38.6% |
| G6001 | Ultrasonic guidance for placement of radiation therapy fields | Office | 2022 | 31 | 529 | $148,120 | $80,816 | 54.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 634 | 908 | $147,091 | $57,386 | 39.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 368 | 455 | $110,110 | $37,687 | 34.2% |
About Dr. Matthew Harris, M.D
Dr. Matthew Harris, M.D is a Dermatology healthcare provider based in Hinsdale, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1497703458.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Matthew Harris, M.D has received a total of $34,135 in payments from pharmaceutical and medical device companies, with $4,437 received in 2024. These payments were reported across 1,239 transactions from 51 companies. The most common payment nature is "Food and Beverage" ($24,062).
As a Medicare-enrolled provider, Harris has provided services to 9,796 Medicare beneficiaries, totaling 23,219 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 87 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Hinsdale, IL
- Active Since 05/04/2006
- Last Updated 04/06/2021
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1497703458
Products in Payments
- RHOFADE (Drug) $1,687
- SKYRIZI (Biological) $1,598
- DUPIXENT (Biological) $1,379
- EPIDUO FORTE (Drug) $1,258
- TREMFYA (Drug) $1,224
- ORACEA (Drug) $1,206
- VTAMA (Drug) $1,145
- AKLIEF (Drug) $1,114
- Otezla (Drug) $774.59
- RINVOQ (Biological) $751.99
- COSENTYX (Biological) $650.75
- EUCRISA (Drug) $645.24
- Humira (Biological) $622.20
- TALTZ (Drug) $617.43
- Ameluz (Drug) $617.19
- Zoryve (Drug) $596.03
- Tremfya (Drug) $592.67
- SOOLANTRA (Drug) $529.02
- Winlevi (Drug) $470.07
- REMICADE (Biological) $467.02
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Hinsdale
Alix Charles, Md, MD
Dermatology — Payments: $42,602
Melanie Zahner, Md, MD
Dermatology — Payments: $24,703
Dr. Carla Sanchez-Palacios, M.d, M.D
Dermatology — Payments: $11,860
Dr. Gina Dillig, M.d, M.D
Dermatology — Payments: $10,517
Miss. Paula Malhotra, M.d, M.D
Dermatology — Payments: $10,195
Dr. Christina Gutierrez-Steil, Md, MD
Dermatology — Payments: $7,608